化学発光免疫測定装置市場レポート：2030年までの動向、予測、競合分析

化学発光免疫測定装置の動向と予測

化学発光免疫測定装置の世界市場は、2024年から2030年までのCAGRが6.6%で、2030年までに推定200億米ドルに達すると予測されます。この市場の主な促進要因は、急性疾患と慢性疾患の罹患率の上昇、化学発光免疫測定装置（CLIA）の技術開発のスピードアップ、慢性疾患の早期発見の重要性に対する意識の高まりです。化学発光免疫測定装置の世界市場の将来は、病院、製薬・バイオテクノロジー企業、臨床検査室市場における機会で有望視されています。

化学発光免疫測定装置市場の洞察

Lucintelは、がん患者の増加や新興国におけるがん検出に関する知識の高まりから、予測期間中もがん領域が最も大きなセグメントであり続けると予測しています。

北米は、米国やカナダなどの国々で構造化されたヘルスケアインフラ施設へのアクセスが容易であること、また化学発光免疫測定装置に関連する研究活動に対する政府資金が増加していることから、予測期間中も最大地域であり続けるでしょう。

よくある質問

Q1.市場規模は？

A1.化学発光免疫測定装置の世界市場は、2030年までに推定200億米ドルに達すると予想されています。

Q2.市場の成長予測は？

A2.化学発光免疫測定装置の世界市場は、2024年から2030年にかけてCAGR 6.6%で成長する見込みです。

Q3.市場の成長に影響を与える主な促進要因は？

A3.この市場の主な促進要因は、急性疾患と慢性疾患の罹患率の上昇、化学発光免疫測定装置（CLIA）の技術開発のスピードアップ、慢性疾患の早期発見の重要性に対する意識の高まりです。

Q4.市場の主要セグメントは？

A4.世界の化学発光免疫測定装置市場の将来は、病院、製薬・バイオ企業、臨床検査市場において有望です。

Q5.市場の主要企業は？

A5.化学発光免疫測定装置の主要企業は以下の通りです。

• Siemens Healthineers
• Diasorin
• Shenzhen Mindray Bio-Medical Electronics
• Abbott Laboratories
• Beckman Coulter
• Immunodiagnostic Systems
• Inova Diagnostics
• F. Hoffmann-La Roche
• Ortho Clinical Diagnostics
• Maccura

Q6.今後、最大となる市場セグメントは？

A6.Lucintelは、がん患者の増加や新興国におけるがん検出に関する知識の増加により、予測期間中、がん領域がより大きなセグメントであり続けると予測しています。

Q7.市場において、今後5年間に最大になると予想される地域は？

A7.北米は、米国やカナダのような国々で整備されたヘルスケアインフラ施設へのアクセスが容易であること、また化学発光免疫測定装置に関連した研究活動に対する政府資金が増加していることから、予測期間中も最大の地域であり続けるであろう。

Q8.レポートのカスタマイズは可能？

A8.はい、Lucintelは追加費用なしで10％のカスタマイズを提供します。

目次

第1章 エグゼクティブサマリー

第2章 世界の化学発光免疫測定装置市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

• マクロ経済動向（2018～2023年）と予測（2024～2030年）
• 世界の化学発光免疫測定装置市場動向（2018-2023）および予測（2024-2030）
• 製品別の世界の化学発光免疫測定装置市場
  • 機器
  • ソフトウェアとサービス
  • 消耗品
• アプリケーション別の世界の化学発光免疫測定装置市場
  • 感染
  • 腫瘍
  • その他
• 最終用途別の世界の化学発光免疫測定装置市場
  • 病院
  • 製薬会社とバイオテクノロジー企業
  • 臨床検査室

第4章 2018年から2030年までの地域別の市場動向と予測分析

• 地域別の世界の化学発光免疫測定装置市場
• 北米の化学発光免疫測定装置市場
• 欧州の化学発光免疫測定装置市場
• アジア太平洋の化学発光免疫測定装置市場
• その他地域の化学発光免疫測定装置市場

第5章 競合の分析

• 製品ポートフォリオ分析
• 運用上の統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 製品別の世界の化学発光免疫測定装置市場の成長機会
  • アプリケーション別の世界の化学発光免疫測定装置市場の成長機会
  • 最終用途別の世界の化学発光免疫測定装置市場の成長機会
  • 地域別の世界の化学発光免疫測定装置市場の成長機会
• 世界の化学発光免疫測定装置市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界の化学発光免疫測定装置市場の能力拡大
  • 世界の化学発光免疫測定装置市場における合併、買収、合弁事業
  • 認証とライセンシング

第7章 有力企業の企業プロファイル

• Siemens Healthineers
• DiaSorin
• Shenzhen Mindray Bio-Medical Electronics
• Abbott Laboratories
• Beckman Coulter
• Immunodiagnostic Systems
• Inova Diagnostics
• F. Hoffmann-La Roche
• Ortho Clinical Diagnostics
• Maccura

Chemiluminescene Immunoassay Analyzer Trends and Forecast

The future of the global chemiluminescene immunoassay analyzer market looks promising with opportunities in the hospital, pharmaceutical & biotech firm, and clinical laboratories markets. The global chemiluminescene immunoassay analyzer market is expected to reach an estimated $20.0 billion by 2030 with a CAGR of 6.6% from 2024 to 2030. The major drivers for this market are rising rates of both acute and chronic illnesses, greater speed at which technology is developing for chemiluminescence immunoassay (CLIA) analyzers, as well as, the rising awareness of the importance of early identification of chronic diseases.

A more than 150-page report is developed to help in your business decisions.

Chemiluminescene Immunoassay Analyzer by Segment

The study includes a forecast for the global chemiluminescene immunoassay analyzer by product, application, end use, and region.

Chemiluminescene Immunoassay Analyzer Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Instruments
• Software & Services
• Consumables

Chemiluminescene Immunoassay Analyzer Market by Application [Shipment Analysis by Value from 2018 to 2030]:

• Infectious Diseases
• Oncology
• Others

Chemiluminescene Immunoassay Analyzer Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Hospitals
• Pharmaceutical & Biotech Firms
• Clinical Laboratories

Chemiluminescene Immunoassay Analyzer Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Chemiluminescene Immunoassay Analyzer Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies chemiluminescene immunoassay analyzer companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the chemiluminescene immunoassay analyzer companies profiled in this report include-

• Siemens Healthineers
• Diasorin
• Shenzhen Mindray Bio-Medical Electronics
• Abbott Laboratories
• Beckman Coulter
• Immunodiagnostic Systems
• Inova Diagnostics
• F. Hoffmann-La Roche
• Ortho Clinical Diagnostics
• Maccura

Chemiluminescene Immunoassay Analyzer Market Insights

Lucintel forecasts that oncology will remain the larger segment over the forecast period due to increase in cancer cases and growing knowledge of its detection in emerging nations.

North America will remain the largest region over the forecast period due to the easy accessibility of well-structured healthcare infrastructure facilities in nations such as the united states and canada, as well as an increase in government funding for research efforts connected to chemiluminescence immunoassay analyzers.

Features of the Global Chemiluminescene Immunoassay Analyzer Market

Market Size Estimates: Chemiluminescene immunoassay analyzer market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Chemiluminescene immunoassay analyzer market size by product, application, end use, and region in terms of value ($B).

Regional Analysis: Chemiluminescene immunoassay analyzer market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, application, end use, and regions for the chemiluminescene immunoassay analyzer market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the chemiluminescene immunoassay analyzer market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the chemiluminescene immunoassay analyzer market size?

Answer: The global chemiluminescene immunoassay analyzer market is expected to reach an estimated $20.0 billion by 2030.

Q2. What is the growth forecast for chemiluminescene immunoassay analyzer market?

Answer: The global chemiluminescene immunoassay analyzer market is expected to grow with a CAGR of 6.6% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the chemiluminescene immunoassay analyzer market?

Answer: The major drivers for this market are rising rates of both acute and chronic illnesses, greater speed at which technology is developing for chemiluminescence immunoassay (CLIA) analyzers, as well as, the rising awareness of the importance of early identification of chronic diseases.

Q4. What are the major segments for chemiluminescene immunoassay analyzer market?

Answer: The future of the global chemiluminescene immunoassay analyzer market looks promising with opportunities in the hospital, pharmaceutical & biotech firm, and clinical laboratories markets.

Q5. Who are the key chemiluminescene immunoassay analyzer market companies?

Answer: Some of the key chemiluminescene immunoassay analyzer companies are as follows.

• Siemens Healthineers
• Diasorin
• Shenzhen Mindray Bio-Medical Electronics
• Abbott Laboratories
• Beckman Coulter
• Immunodiagnostic Systems
• Inova Diagnostics
• F. Hoffmann-La Roche
• Ortho Clinical Diagnostics
• Maccura

Q6. Which chemiluminescene immunoassay analyzer market segment will be the largest in future?

Answer: Lucintel forecasts that oncology will remain the larger segment over the forecast period due to increase in cancer cases and growing knowledge of its detection in emerging nations.

Q7. In chemiluminescene immunoassay analyzer market, which region is expected to be the largest in next 5 years?

Answer: North America will remain the largest region over the forecast period due to the easy accessibility of well-structured healthcare infrastructure facilities in nations such as the united states and canada, as well as an increase in government funding for research efforts connected to chemiluminescence immunoassay analyzers.

Q8. Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the chemiluminescene immunoassay analyzer market by product (instruments, software & services, and consumables), application (infectious diseases, oncology, and others), end use (hospitals, pharmaceutical & biotech firms, and clinical laboratories), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Chemiluminescene Immunoassay Analyzer Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Chemiluminescene Immunoassay Analyzer Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Chemiluminescene Immunoassay Analyzer Market by Product
  • 3.3.1: Instruments
  • 3.3.2: Software & Services
  • 3.3.3: Consumables
• 3.4: Global Chemiluminescene Immunoassay Analyzer Market by Application
  • 3.4.1: Infectious Diseases
  • 3.4.2: Oncology
  • 3.4.3: Others
• 3.5: Global Chemiluminescene Immunoassay Analyzer Market by End Use
  • 3.5.1: Hospitals
  • 3.5.2: Pharmaceutical & Biotech Firms
  • 3.5.3: Clinical Laboratories

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Chemiluminescene Immunoassay Analyzer Market by Region
• 4.2: North American Chemiluminescene Immunoassay Analyzer Market
  • 4.2.1: North American Chemiluminescene Immunoassay Analyzer Market by Application: Infectious Diseases, Oncology, and Others
  • 4.2.2: North American Chemiluminescene Immunoassay Analyzer Market by End Use: Hospitals, Pharmaceutical & Biotech Firms, and Clinical Laboratories
• 4.3: European Chemiluminescene Immunoassay Analyzer Market
  • 4.3.1: European Chemiluminescene Immunoassay Analyzer Market by Application: Infectious Diseases, Oncology, and Others
  • 4.3.2: European Chemiluminescene Immunoassay Analyzer Market by End Use: Hospitals, Pharmaceutical & Biotech Firms, and Clinical Laboratories
• 4.4: APAC Chemiluminescene Immunoassay Analyzer Market
  • 4.4.1: APAC Chemiluminescene Immunoassay Analyzer Market by Application: Infectious Diseases, Oncology, and Others
  • 4.4.2: APAC Chemiluminescene Immunoassay Analyzer Market by End Use: Hospitals, Pharmaceutical & Biotech Firms, and Clinical Laboratories
• 4.5: ROW Chemiluminescene Immunoassay Analyzer Market
  • 4.5.1: ROW Chemiluminescene Immunoassay Analyzer Market by Application: Infectious Diseases, Oncology, and Others
  • 4.5.2: ROW Chemiluminescene Immunoassay Analyzer Market by End Use: Hospitals, Pharmaceutical & Biotech Firms, and Clinical Laboratories

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Chemiluminescene Immunoassay Analyzer Market by Product
  • 6.1.2: Growth Opportunities for the Global Chemiluminescene Immunoassay Analyzer Market by Application
  • 6.1.3: Growth Opportunities for the Global Chemiluminescene Immunoassay Analyzer Market by End Use
  • 6.1.4: Growth Opportunities for the Global Chemiluminescene Immunoassay Analyzer Market by Region
• 6.2: Emerging Trends in the Global Chemiluminescene Immunoassay Analyzer Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Chemiluminescene Immunoassay Analyzer Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Chemiluminescene Immunoassay Analyzer Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Siemens Healthineers
• 7.2: DiaSorin
• 7.3: Shenzhen Mindray Bio-Medical Electronics
• 7.4: Abbott Laboratories
• 7.5: Beckman Coulter
• 7.6: Immunodiagnostic Systems
• 7.7: Inova Diagnostics
• 7.8: F. Hoffmann-La Roche
• 7.9: Ortho Clinical Diagnostics
• 7.10: Maccura